Home
Results for: Tom McKillop
Wikipedia (1 of 2 sources) Open/Close data Source
Tom McKillop

Sir Thomas Fulton Wilson McKillop, born 19 March 1943, is a chemist, former pharmaceutical company CEO and former chairman of RBS Group.

The Royal Bank of Scotland's office in Fleet Street, London- also home to Child & Co.

McKillop was born in Dreghorn, a small village near the town of Irvine in Ayrshire, Scotland and educated at Irvine Royal Academy and then Glasgow University, where he took a BSc Hons and PhD in Chemistry. He joined ICI's Corporate Research Laboratory at Runcorn in 1969 after post-doctoral research work in Paris. He moved to ICI Pharmaceuticals Division in 1975 and, having held a number of positions in Research, in 1989 he was appointed Technical Director of ICI Pharmaceuticals with international responsibility for research, development and production.

Contents

Zeneca

In 1993, ICI Pharmaceuticals demerged to become Zeneca, and in 1994 he was appointed Chief Executive Officer of the new company. In April 1999, Zeneca merged with Astra to form AstraZeneca PLC and McKillop became Chief Executive of the merged company. He retired early from AstraZeneca on the 1st January 2006, when David Brennan took over the role of AstraZeneca CEO. After leaving AstraZeneca he became the chairman of the Royal Bank of Scotland.

RBS

He chaired RBS during the tenure of CEO Fred Goodwin, who promoted aggressive expansion of the bank by acquiring other banks. From the time that Goodwin took over as chief executive until 2007, RBS's assets quadrupled, its cost-to-income ratio improved markedly, and its profits soared. In 2006 pre-tax profits climbed 16% to £9.2 billion with most of the growth coming from its investment banking business.[citation needed] By 2008 RBS was the fifth-largest bank in the world by market capitalization.[1] One of the factors in its rise was its enthusiasm for supporting leveraged buyouts. In 2008 it lent $9.3bn, more than double its nearest rival.[2]

However, following investor unrest in the build-up to RBS's acquisition of a $1.6bn minority stake in Bank of China in 2005 Goodwin was criticised by some RBS shareholders for putting global expansion ahead of short-term financial returns.[1] Between 2002 and 2005 the share price plateaud at around £17 per share, having nearly trebled between February 2000 and May 2002.[3] Goodwin was accused of megalomania by some shareholders, as reported by Dresdner Kleinwort analyst James Eden (who said he thought the label was 'unwarranted').[4] After the Bank of China deal, he was forced to promise RBS shareholders he would not indulge in any further big acquisitions and focus instead on growing the group organically.[1]

However, in early 2007 Dutch bank ABN AMRO was under pressure from hedge funds, including Chris Hohn of the hedge fund TCI, to break itself up in order to maximise shareholder value. ABN chief executive Rijkman Groenink suspected RBS of acting in concert with the hedge fund Tosca, which was chaired by former RBS Chairman Mathewson and recommended the takeover bid of an RBS consortium, against the proposed merger with Barclays Bank.[5] Goodwin arranged a consortium of RBS, Fortis and former RBS shareholders Grupo Santander, to purchase the assets of ABN AMRO and break them up in a three-way split. According to the proposed deal, RBS would take over ABN's Chicago operations, LaSalle Bank, and ABN's wholesale operations; while Santander would take the Brazilian operations and Fortis the Dutch operations. In a manoeuvre "labelled in all quarters as a poison pill"[5] ABN AMRO agreed to sell key RBS target LaSalle to Bank of America for $21bn, but in July 2007 the consortium offered the same $98bn for ABN's remaining assets, with a higher cash component (93%).[6] The deal was struck in October 2007 as the global liquidity crisis began to develop, with Barclays withdrawing its EUR61bn bid and ABN's shareholders endorsing the EUR71bn RBS takeover.[5] Coming after the nationalisation of Northern Rock due to the freezing of the wholesale money markets, the deal proved the final straw for RBS, as it severely weakened its balance sheet not only through the size of the acquisition but due to ABN AMRO's substantial exposure to the US subprime mortgage crisis.[1]

While at the Royal Bank of Scotland the value of Royal Bank of Scotland shares fell below a quarter of their level in early 2007. Following criticism from the press for the takeover of ABN AMRO and the UK government having to bail out the bank, Sir Tom McKillop announced his early retirement as Chairman of the Royal Bank of Scotland on 13 October 2008. At a meeting of the Treasury Select Committee of the House of Commons on February 10, 2009, he admitted to having no qualifications in banking. Like the other retired bankers present, he also apologised for the financial crisis.[7]

Awards

Other

He currently remains a non-executive director of BP, having been a non-executive director of Lloyds TSB Group plc from 1999-2004. He is also Chairman of the British Pharma Group, Pro-Chancellor of the University of Leicester, Vice-President of the European Federation of Pharmaceutical Industries and Associations and Chairman of the North West Science Council. He was awarded the Society of Chemical Industry's annual Centenary Medal in 2005. In January 2007 he took up the post of President of the Science Council. His brother, Alexander (Sandy) McKillop, was Professor of Organic Chemistry at the University of East Anglia from 1970 to 1996.

See also

References

  1. ^ a b c d Arnott, Sarah (2008-10-14). "The rise and fall of 'Fred the Shred' - Business Analysis & Features, Business". London: The Independent. http://www.independent.co.uk/news/business/analysis-and-features/the-rise-and-fall-of-fred-the-shred-960336.html. Retrieved 2009-02-27. 
  2. ^ Wall Street Journal blog, 7 January 2009, [1]
  3. ^ The Sunday Herald, 17 November 2005, Goodwin's Turning Point
  4. ^ The Independent, 5 August 2005, [2]
  5. ^ a b c The Daily Telegraph, 9 October 2007, RBS on brink of declaring victory in ABN battle
  6. ^ Marketwatch, 16 July 2007, Timeline of the battle for ABN AMRO
  7. ^ Farrell, Sean (2009-02-11). "Treasury Select Committee: Bonfire of the bankers - Business Analysis & Features, Business". London: The Independent. http://www.independent.co.uk/news/business/analysis-and-features/treasury-select-committee-bonfire-of-the-bankers-1606332.html. Retrieved 2009-03-04. 
  8. ^ Honorary Degrees 2004, University of St Andrews, April 15, 2004, accessed January 19, 2011.

External links



This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)

logo This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article Tom McKillop.

Mentioned In Open/Close data Source